Zayd Alathari joined SABIC in February 2012 and is based in Riyadh. He is responsible for a team of attorneys and IP practitioners handling all aspects of intellectual property work for a number of Business Units, Manufacturing and Technology & Innovation teams in developing and implementing IP strategy, providing legal and IP counseling and contract support to enhance the value of SABIC technology. The team’s responsibilities include advising on, drafting and negotiating technology related agreements and patent portfolio management, patent preparation, prosecution and maintenance, freedom-to-practice, patent litigation and IP due diligence.
Dr. Ahmed Alaskar is a Consultant and Associate Professor, Adult Hematology & Stem Cell Transplantation, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs. He is also the Executive Director, King Abdullah International Medical Research Center and the President of Saudi Society of Blood and Marrow Transplantation (SSBMT).
Dr. Alaskar gained his MBBS from King Saud University and completed medical trainings at University of British Columbia, Vancouver, Canada where he obtained both the Canadian and the American Boards of Internal Medicine and of Hematology and Stem Cells Transplantation.
Dr. Alaskar assumed numerous administrative tasks and positions since 2001. He was the Director, Inpatient Services at King Abdulaziz Medical City – Riyadh and the Program Director of the Saudi Board Preparatory Course for Internal Medicine. He led the Department of Oncology at its establishment stage in 2005/2006 while he continued to be the Head, Division of Adult Hematology & Hematopoietic Stem Cell Transplantation until March 2015. He was one of the founders of the Saudi Scientific Society of Blood and Marrow Transplantation in the Kingdom of Saudi Arabia and was elected twice to be the President of the society. He was then appointed as Deputy Executive Director, King Abdullah International Medical Research Center from May 2010 and became the Executive Director in September 2013 until present.
Dr. Alaskar has a number of publications and involved in numerous local and national committees and member of several International Societies.
Head, Strategy & Business Development, KAIMRC / Managing Director, Medical Biotechnology Park, KAIMRC
Dr. Haoudi is currently leading the Strategy and Business Development and is also Managing Director of the Biotechnology Park at King Abdullah International Medical Research Center at the Ministry of National Guard Health Affairs, and is also Distinguished Scholar at Harvard University/Boston Children’s Hospital.
Dr. Haoudi is an international Research & Development and Innovation Executive with over 25 years experience, having held several senior positions in Research and Development and Innovation, including Founding Vice President for Research and Executive Director for R&D and Managing Director for Biotechnology Industrial Park. Vast experience in science and technology policy development, strategy and Business development, Review and Assessment, feasibility studies and Corporate Development and International Partnerships Development.
Dr. Haoudi held several senior and prestigious positions in the academia, government and private sectors. Dr. Haoudi was also Research Professor of cancer and infectious diseases at the University of Virginia and Eastern Virginia Medical School and a fellow of the US National Institutes of Health. He has also held several other positions in elite research and education institutions including Visiting Professor at Harvard Medical School (USA) and a fellow at Institut Pasteur (France) and had served as consultant and advisor to several biotechnology and pharmaceutical companies.
Dr. Haoudi was elected as a member of the Royal Academy for Sciences and Technology since 2006 and graduated from University Paris XI and Paris VI, France in 1996 with a doctoral degree in cellular and molecular genetics and received executive education from Harvard Business School in Corporate Management and Strategy and Intellectual Property.
Amit heads IQVIA’S business in Africa, Middle East and South Asia and has led the company’s operations in the region since 2012. He has been pivotal in providing healthcare customers end-to-end management of their commercial, clinical and operational functions.
Amit co-founded PharmARC, a provider of analytics services to global healthcare companies spread across India, Europe and the US. He joined IQVIA with the sale of the 300 people strong PharmARC to IQVIA (then IMS Health) in January 2012.
Experience: Amit has over two decades of experience in driving commercial healthcare engagements at global and regional levels. He has worked with large manufacturers, payors, providers, government and donor agencies in varied analytics, consulting and technology engagements across the globe. Prior to co-founding PharmARC, he worked with MNCs such as F. Hoffman La Roche and Bristol-Myers Squibb.
Education: Amit holds a master’s degree in Statistics and bachelor’s in Mathematics from the New Jersey Institute of Technology, NJ.
Chief Operating Officer, Technlology Development and Investment Company (TAQNIA)
Abdulelah Alnemr is currently the Chief Operating Officer at The Saudi Technology Development and Investment Company (TAQNIA) a wholly owned subsidiary of the Saudi Public Investment Fund (PIF) that is mandated on investing in local and international technologies and developing them into commercially viable enterprises.
Abdulelah has 15 years of experience and filled executive positions, business and project development, stategy, creating partnerships, corporate investment banking, and project financing.
Prior to joining TAQNIA, Abdulelah worked at Riyad Capital corporate investment banking division as an Assistant Vice President and at the Saudi Industrial Development Fund (SIDF) as a lending team leader.
He has led and contributed to the closure of several successful debt and equity transactions, advised and evaluated greenfield and brownfield industrial projects across different sectors including health care, building materials, pertochemicals, defense, research and development, technology investment with a total value of around SAR 15 billion.
He has completed numerous training programs including the executive development program from Wharton Business School.
Abdulelah obtained his bachelor degree in Finance & Economics with distinction from King Fahd University of Petroleum & Minerals.